Concepedia

LBA37 A randomized, multicentric phase II study of preoperative nivolumab plus relatlimab or nivolumab in patients with resectable non-small cell lung cancer (NEOpredict-Lung)

M.H.H. Schuler, K. Cuppens, T. Ploenes, M. Vanbockrijck, M. Wiesweg, K. Darwiche, A. Schramm, Brigitte Maes, B. Hegedus, Hans‐Ulrich Schildhaus,

Annals of Oncology · 2022 · 11 citations · 0 references

Open access

Concepts

MedicineOncologySurgeryOncologic SurgerySurgical OncologyThoracic OncologyCancer ImmunotherapyLung CancerNeoadjuvant ImmunotherapyPulmonary ResectionThoracic Oncology SurgeryThoracic SurgeryNon-small Cell Lung Cancer Adjuvant TherapyNon-small Cell Lung Cancer ImmunotherapyNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentPhase Ii Investigation